These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Increased expression of myocardial semaphorin 3A in isoproterenol-induced heart failure rats. Sun SQ; Wang XT; Qu XF; Li Y; Yu Y; Song Y; Wang SJ Chin Med J (Engl); 2011 Jul; 124(14):2173-8. PubMed ID: 21933622 [TBL] [Abstract][Full Text] [Related]
44. [Cardiomyocyte apoptosis and death receptor pathway in a rat model of coronary microembolization]. Li L; Su Q; Wang Y; Su B; Dai RX; Lu YG; Wu XH; Liu TW Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):363-8. PubMed ID: 20654086 [TBL] [Abstract][Full Text] [Related]
45. DNA microarray and quantitative analysis reveal enhanced myocardial VEGF expression with stunted angiogenesis in human tetralogy of Fallot. Peters TH; Sharma V; Yilmaz E; Mooi WJ; Bogers AJ; Sharma HS Cell Biochem Biophys; 2013 Nov; 67(2):305-16. PubMed ID: 23897578 [TBL] [Abstract][Full Text] [Related]
46. Transcatheter arterial infusion with heated saline changes the vascular permeability of rabbit hepatic tumors. Cao W; Lu Q; Li JH; Zhou CX; Zhu J; Wan Y; Liu YF Acad Radiol; 2011 Dec; 18(12):1569-76. PubMed ID: 21968263 [TBL] [Abstract][Full Text] [Related]
47. High thoracic sympathetic block improves coronary microcirculation disturbance in rats with chronic heart failure. Sun G; Liu F; Xiu C Microvasc Res; 2019 Mar; 122():94-100. PubMed ID: 30513283 [TBL] [Abstract][Full Text] [Related]
48. BACE1 levels are elevated in congestive heart failure. Nural-Guvener HF; Mutlu N; Gaballa MA Neurosci Lett; 2013 Jan; 532():7-11. PubMed ID: 23127855 [TBL] [Abstract][Full Text] [Related]
49. The role of ERK1/2 signaling pathway in coronary microembolization-induced rat myocardial inflammation and injury. Li L; Li DH; Qu N; Wen WM; Huang WQ Cardiology; 2010; 117(3):207-15. PubMed ID: 21150201 [TBL] [Abstract][Full Text] [Related]
50. Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway. Li H; Yang H; Qin Z; Wang Q; Li L BMC Cardiovasc Disord; 2024 Jan; 24(1):23. PubMed ID: 38172692 [TBL] [Abstract][Full Text] [Related]
51. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Beauloye C; Bertrand L; Horman S; Hue L Cardiovasc Res; 2011 May; 90(2):224-33. PubMed ID: 21285292 [TBL] [Abstract][Full Text] [Related]
52. Influence of polymeric microspheres on the myocardial oxygen partial pressure in the beating heart of pigs. Hiebl B; Mrowietz C; Lee S; Braune S; Knaut M; Lendlein A; Franke RP; Jung F Microvasc Res; 2011 Jul; 82(1):52-7. PubMed ID: 21497610 [TBL] [Abstract][Full Text] [Related]
53. Partial persistence of exercise-induced myocardial angiogenesis following 4-week detraining in the rat. Marini M; Falcieri E; Margonato V; Treré D; Lapalombella R; di Tullio S; Marchionni C; Burattini S; Samaja M; Esposito F; Veicsteinas A Histochem Cell Biol; 2008 Apr; 129(4):479-87. PubMed ID: 18172661 [TBL] [Abstract][Full Text] [Related]
54. Measurement of AMP-activated protein kinase activity and expression in response to ghrelin. Lim CT; Lolli F; Thomas JD; Kola B; Korbonits M Methods Enzymol; 2012; 514():271-87. PubMed ID: 22975059 [TBL] [Abstract][Full Text] [Related]